Home » Bills Could Curb Generic Firms' Ability to Fight Brand Patents
Bills Could Curb Generic Firms' Ability to Fight Brand Patents
October 3, 2006
Patent reform bills pending in the House and Senate would enact sweeping changes to existing patent laws, to the detriment of generic drug companies, if passed by Congress, one legal
expert said at a recent industry conference.